Single ‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: a cross‐trial comparison of phase 3 studies

American Journal of Hematology,Volume 0, Issue ja, -Not available-.

Source: American Journal of Hematology - August 21, 2018 Category: Hematology Authors: Tadeusz Robak MD, PhD , Jan A. Burger MD, PhD , Alessandra Tedeschi MD , Paul M. Barr MD , Carolyn Owen MD , Osnat Bairey MD , Peter Hillmen MBChB, PhD , David Simpson MBChB, FRACP, FRCPA , Sebastian Grosicki MD, PhD , Source Type: research